Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gsk Plc ADR
(NY:
GSK
)
42.63
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gsk Plc ADR
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
30
31
Next >
Sanofi Records Q4 Topline, Bottomline Growth As Blockbuster Eczema Drug Soars
February 04, 2022
Sanofi SA's (NASDAQ: SNY)
Via
Benzinga
GSK To Get $1.25B As Settlement For HIV Treatment Drug Patent Row With Gilead
February 02, 2022
GlaxoSmithKline plc (NYSE: GSK) has settled a patent dispute between ViiV Healthcare and Gilead Sciences Inc (NASDAQ: GILD).
Via
Benzinga
World Markets News for Tuesday
February 01, 2022
Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon.
Via
Talk Markets
FDA Approves First Injectable For HIV Pre-Exposure Prevention - GSK, Pfizer Backed Treatment
February 01, 2022
The FDA has approved ViiV Healthcare's Apretude (cabotegravir extended-release injectable suspension
Via
Benzinga
Panic reversal
January 26, 2022
Crude oil inventories turned out to be fuller than expected, helping reduce the oil price rise.
Via
Talk Markets
10 Stocks to Buy That Could Make You a Millionaire in 2022
January 26, 2022
After this past year, it's going to be hard to find stocks to buy to make you a millionaire in 2022. Here are 10 that might do the trick.
Via
InvestorPlace
Markets Fears
January 24, 2022
Today markets dropped precipitously over fear of a Ukrainian invasion and higher interest rates and inflation.
Via
Talk Markets
FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors
January 24, 2022
The FDA has cleared Lyell Immunopharma Inc's (NASDAQ: LYEL) Investigational New Drug (IND) application to initiate a Phase 1 trial for LYL132 in solid tumors....
Via
Benzinga
Activist Investor Nelson Peltz's Fund Buys Stake In Unilever: FT
January 23, 2022
Trian Fund Management LP, the activist hedge fund run by Nelson Peltz, has built a stake in Unilever PLC (NYSE: UL), the Financial Times reports, citing people with direct...
Via
Benzinga
Why Jim Cramer Like NextEra Energy And Lincoln Electric?
January 21, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said NextEra Energy, Inc. (NYSE:
Via
Benzinga
World Markets News
January 20, 2022
Today oil and gas inventories were seen as higher than expected while potential prices fell, both bullish.
Via
Talk Markets
Wednesday File
January 19, 2022
It sound odd but the real threat to markets is slowing Chinese growth which fell to 4% in Q4 from double that earlier last year.
Via
Talk Markets
Chopped Stocks
January 18, 2022
The day's theme is sell tech and buy banks.
Via
Talk Markets
23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?
January 18, 2022
Genetic testing company 23andMe Holding Co. (NASDAQ: ME) took the unconventional route of a SPAC deal to go public, and the stock hasn't gained much traction since it began...
Via
Benzinga
GSK Spurns $68.4B Bid From Unilever For Its Consumer Healthcare Business, Opts to Spin-off The Unit
January 15, 2022
GlaxoSmithKline rejects three purchase offers from Unilever for its Consumer Healthcare business. The U.K. pharma giant says the business is well-positioned to...
Via
Benzinga
More Serious Matters
January 14, 2022
Wall Street fell on new worries about inflation and a drop in retail sales levels.
Via
Talk Markets
Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK)
January 14, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Shares of GlaxoSmithKline PLC (NYSE: GSK...
Via
Benzinga
WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge
January 14, 2022
An expert panel at the World Health Organization (WHO) recommended the use of treatments developed by Eli Lilly And Co (NYSE: LLY) and GlaxoSmithKline Plc...
Via
Benzinga
Two Curses Of The Current Year
January 13, 2022
The good news on inflation after this week's shocker is that December wholesale prices only rose 0.2%.
Via
Talk Markets
GSK, Vir Biotech File For Emergency Use Nod For Intramuscular Sotrovimab For COVID-19
January 13, 2022
GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have applied to the FDA to include intramuscular (IM) administration to sotrovimab...
Via
Benzinga
Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies
January 13, 2022
Adagio Therapeutics Inc (NASDAQ: ADGI) shares gain during the premarket session after recent findings showing that ADG20 has neutralization activity against the omicron...
Via
Benzinga
US To Purchase 600K Additional Doses of GSK-Vir's COVID-19 Antibody Therapy
January 11, 2022
The U.S. has agreed to buy 600,000 more doses of GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR) COVID-19 antibody...
Via
Benzinga
CureVac Outlines Upcoming Catalysts For Vaccine Programs
January 10, 2022
Ahead of J.P. Morgan Healthcare Conference, CureVac BV (NASDAQ: CVAC) outlined the timeline for its vaccine programs. CureVac's preclinical second-...
Via
Benzinga
Market Briefing For Wednesday, Jan. 5
January 05, 2022
Rising interest rates have yet to spark overt action by the Fed nor yet to cool-off the hot real estate market. However, the Nasdaq was hit hard, presumably as the 10-year rallied.
Via
Talk Markets
Market Trend: Erratic And Unreliable
December 29, 2021
Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is.
Via
Talk Markets
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
December 29, 2021
Pfizer (NYSE: PFE) is arguably one of the biggest leaders in COVID-19 technology, whether it’s their vaccine or their newly approved oral antiviral called Paxlovid. The...
Via
Benzinga
Pfizer's CEO Shows You How To Get 'Impossible' Tasks Done Fast
December 29, 2021
Scientists told the Pfizer CEO they could create a vaccine in 18 months. But Albert Bourla knew they could work even faster.
Via
Investor's Business Daily
A Bit Of Good News
December 22, 2021
US growth figures for Q3 were up from forecasts of 2.1% at 2.3% but well down from the prior quarter level of 6.7%.
Via
Talk Markets
GSK Option Bulls Get Head Start on Cup & Handle
December 21, 2021
Pharma has been one of the best performing industries in recent weeks and GlaxoSmithKline has been among the top performers. Today, it appears that call buyers are stepping into the stock as it tests...
Via
Talk Markets
The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail
December 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CytomX Mid-Phase Study Of ADC In Lung And Head & Neck Cancer Patients...
Via
Benzinga
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.